ITCI vs. VOO
Compare and contrast key facts about Intra-Cellular Therapies, Inc. (ITCI) and Vanguard S&P 500 ETF (VOO).
VOO is a passively managed fund by Vanguard that tracks the performance of the S&P 500 Index. It was launched on Sep 7, 2010.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ITCI or VOO.
Correlation
The correlation between ITCI and VOO is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ITCI vs. VOO - Performance Comparison
Key characteristics
ITCI:
1.30
VOO:
1.89
ITCI:
3.12
VOO:
2.54
ITCI:
1.38
VOO:
1.35
ITCI:
3.75
VOO:
2.83
ITCI:
8.03
VOO:
11.83
ITCI:
8.71%
VOO:
2.02%
ITCI:
53.73%
VOO:
12.66%
ITCI:
-87.64%
VOO:
-33.99%
ITCI:
-0.05%
VOO:
-0.42%
Returns By Period
In the year-to-date period, ITCI achieves a 53.90% return, which is significantly higher than VOO's 4.17% return. Over the past 10 years, ITCI has outperformed VOO with an annualized return of 17.58%, while VOO has yielded a comparatively lower 13.26% annualized return.
ITCI
53.90%
1.61%
72.86%
75.41%
39.23%
17.58%
VOO
4.17%
1.23%
10.51%
24.45%
14.68%
13.26%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ITCI vs. VOO — Risk-Adjusted Performance Rank
ITCI
VOO
ITCI vs. VOO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ITCI vs. VOO - Dividend Comparison
ITCI has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.19%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ITCI Intra-Cellular Therapies, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VOO Vanguard S&P 500 ETF | 1.19% | 1.24% | 1.46% | 1.69% | 1.25% | 1.54% | 1.88% | 2.06% | 1.78% | 2.02% | 2.10% | 1.85% |
Drawdowns
ITCI vs. VOO - Drawdown Comparison
The maximum ITCI drawdown since its inception was -87.64%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for ITCI and VOO. For additional features, visit the drawdowns tool.
Volatility
ITCI vs. VOO - Volatility Comparison
The current volatility for Intra-Cellular Therapies, Inc. (ITCI) is 0.95%, while Vanguard S&P 500 ETF (VOO) has a volatility of 2.94%. This indicates that ITCI experiences smaller price fluctuations and is considered to be less risky than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.